Risk classification of steatotic liver patients and event incidence rates at five years by risk category. Credit: Osaka University Researchers at Osaka University have found that patients with steatotic liver disease who have high levels of growth differentiation factor 15 (GDF15) in their blood are more likely to develop liver cancer. By combining blood GDF15 levels with liver stiffness indicators, it is possible to more effectively identify patients at high risk of developing liver cancer, experiencing liver deterioration, and having poor outcomes. The findings are published in the journal Alimentary Read More